{"id":7383,"date":"2008-07-09T13:38:00","date_gmt":"2008-07-09T13:38:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/pharma-vendor-and-ad-agency-diversity\/"},"modified":"2019-02-21T01:24:43","modified_gmt":"2019-02-21T01:24:43","slug":"pharma-vendor-and-ad-agency-diversity","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-vendor-and-ad-agency-diversity\/","title":{"rendered":"Pharma Vendor and Ad Agency Diversity: All Talk, No Action?"},"content":{"rendered":"

\"\"<\/a>Craig DeLarge, Associate Director, eMarketing & Relationship Marketing at Novo Nordisk Inc., was a featured speaker at the 4th Annual Pharma Networking Dinner Reception that I hosted at the Princeton, NJ Marriott on June 4, 2008.<\/p>\n

DeLarge spoke on the Life Science Profiles of Color Project and blog (see here<\/a>), the goals of which are to encourage and offer guidance to young people seeking to achieve success in the life sciences industry and to highlight the contribution of people of color in the life sciences.<\/p>\n

DeLarge’s profile<\/a> is the first one published on the LSPOC blog. He ended his LSPOC profile with these words:<\/p>\n

“The benefits of the industry\u2019s diversity initiatives, racially and otherwise,” says DeLarge, “have been greater reflection of our customers in our organizations with the corresponding benefits of greater innovation and openness, customer empathy and broader more relevant perspectives. While there is always more to be done, in 20 years, I have seen pharma manufacturers come along way. That said, the service and vendor sides of the industry is seemingly lagging behind its clients.”<\/p>\n

The issue of diversity\u2014or lack thereof\u2014in the NYC advertising agency world was highlighted recently in the AdAge blog post \u201cAgencies Have Funny Way of Showing ‘Commitment’ to Diversity<\/a>\u201d by Ken Wheaton who criticized the lack of ad agency presence at a recent New York City Commission on Human Rights public meeting.<\/p>\n

\n\u201c\u2026 it’s not fun to sit there and put faces and names to the stories you hear in the industry,\u201d wrote Wheaton. \u201cIt’s not fun to see grown men and women wrestling with a mix of pride and frustration, to sense that they’re just this close to throwing their hands up in defeat and that you, an agency executive, are partly responsible. It’s uncomfortable to hear a 20-something black man who has an agency job call this \u2018the most discouraging business to be in.\u2019 It isn’t easy to try to distill the cases of racial discrimination from those of talent discrimination, to parse the inside stories and personal grudges that haunt a corner of the industry that most executives probably don’t even know exist.\u201d<\/p>\n

\u201cThere are many reasons why the agency world looks more like a gated community than a global one,\u201d wrote Wheaton. \u201cThere is a lack of awareness in certain minority enclaves; portfolio schools are expensive. The starting pay stinks for qualified candidates who can get better jobs with marketers. Not all of these are excuses.<\/p>\n

\u201cBut they start to sound that way when the executives in question don’t have the decency to give the problem its due, don’t have the balls to show up in person and look these people in the eye.<\/p>\n

\u201cNot showing up also allows charges to go unanswered. Rafee Kamaal, a TV producer, likened the industry to insects when calling for more attention to the matter. \u2018Roaches scatter when you shine the light on them.\u2019 Others said that a system of discrimination is \u2018embedded in the industry.\u2019 Euro RSCG was named-checked no fewer than three times in last night’s meeting — and it wasn’t for enlightened hiring practices.\u201d<\/p>\n

Comments to Wheaton\u2019s tirade include the following:<\/p>\n

\n\u201cThe problem isn’t NYC tho. As I and others can attest, it’s not just a New York thing. If the will and the stomach for seeing the mess out in the open were there, you could hold hearings in every city from Orange County, NJ to Orange County, CA and you’d find exactly the same level of collusion and bias in effect.\u201d — \u2013Eric J. Henderson, New York, NY<\/p>\n

\u201cI’ve seen what happens when you speak out in this industry. I’ve seen it up close and personal. It’s not pretty what can be done to you. Personally, I’ve had enough. It’s a broken system and there are too many people who enjoy maintaining the status quo.\u201d \u2013hadji williams, chicago, IL<\/p>\n

UPDATE: Of the 16 ad agencies forced to sign diversity-hiring agreements with the New York Commission on Human Rights in 2006, only two sent representatives to the latest progress meeting this week. Ad Age Features and Blogs Editor Ken Wheaton was a member of the tiny audience at that gathering. He wonders aloud how companies that are such experts in creating and nurturing corporate images can so neglect their own when it comes to racial diversity. See video here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

Craig DeLarge, Associate Director, eMarketing & Relationship Marketing at Novo Nordisk Inc., was a featured speaker at the 4th Annual Pharma Networking Dinner Reception that I hosted at the Princeton, NJ Marriott on June 4, 2008. DeLarge spoke on the Life Science Profiles of Color Project and blog (see here), the goals of which are […]<\/p>\n","protected":false},"author":2,"featured_media":13101,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12],"tags":[457,1066,1067,1068,1069],"topic":[],"acf":[],"yoast_head":"\nPharma Vendor and Ad Agency Diversity: All Talk, No Action? - Pharma Marketing Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-vendor-and-ad-agency-diversity\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma Vendor and Ad Agency Diversity: All Talk, No Action? - Pharma Marketing Network\" \/>\n<meta property=\"og:description\" content=\"Craig DeLarge, Associate Director, eMarketing & Relationship Marketing at Novo Nordisk Inc., was a featured speaker at the 4th Annual Pharma Networking Dinner Reception that I hosted at the Princeton, NJ Marriott on June 4, 2008. DeLarge spoke on the Life Science Profiles of Color Project and blog (see here), the goals of which are […]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-vendor-and-ad-agency-diversity\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Marketing Network\" \/>\n<meta property=\"article:published_time\" content=\"2008-07-09T13:38:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-02-21T01:24:43+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2019\/03\/pmn-logo-intro-post-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"744\" \/>\n\t<meta property=\"og:image:height\" content=\"419\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pharma Guy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pharma Guy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-vendor-and-ad-agency-diversity\/\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-vendor-and-ad-agency-diversity\/\",\"name\":\"Pharma Vendor and Ad Agency Diversity: All Talk, No Action? - Pharma Marketing Network\",\"isPartOf\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\"},\"datePublished\":\"2008-07-09T13:38:00+00:00\",\"dateModified\":\"2019-02-21T01:24:43+00:00\",\"author\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\"},\"breadcrumb\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-vendor-and-ad-agency-diversity\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-vendor-and-ad-agency-diversity\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-vendor-and-ad-agency-diversity\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma Vendor and Ad Agency Diversity: All Talk, No Action?\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\",\"name\":\"Pharma Marketing Network\",\"description\":\"Pharma Marketing Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\",\"name\":\"Pharma Guy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/\",\"url\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"contentUrl\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"caption\":\"Pharma Guy\"},\"description\":\"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharma Vendor and Ad Agency Diversity: All Talk, No Action? - Pharma Marketing Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-vendor-and-ad-agency-diversity\/","og_locale":"en_US","og_type":"article","og_title":"Pharma Vendor and Ad Agency Diversity: All Talk, No Action? - Pharma Marketing Network","og_description":"Craig DeLarge, Associate Director, eMarketing & Relationship Marketing at Novo Nordisk Inc., was a featured speaker at the 4th Annual Pharma Networking Dinner Reception that I hosted at the Princeton, NJ Marriott on June 4, 2008. DeLarge spoke on the Life Science Profiles of Color Project and blog (see here), the goals of which are […]","og_url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-vendor-and-ad-agency-diversity\/","og_site_name":"Pharma Marketing Network","article_published_time":"2008-07-09T13:38:00+00:00","article_modified_time":"2019-02-21T01:24:43+00:00","og_image":[{"width":744,"height":419,"url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2019\/03\/pmn-logo-intro-post-1.jpg","type":"image\/jpeg"}],"author":"Pharma Guy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pharma Guy","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-vendor-and-ad-agency-diversity\/","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-vendor-and-ad-agency-diversity\/","name":"Pharma Vendor and Ad Agency Diversity: All Talk, No Action? - Pharma Marketing Network","isPartOf":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website"},"datePublished":"2008-07-09T13:38:00+00:00","dateModified":"2019-02-21T01:24:43+00:00","author":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1"},"breadcrumb":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-vendor-and-ad-agency-diversity\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-vendor-and-ad-agency-diversity\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-vendor-and-ad-agency-diversity\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/"},{"@type":"ListItem","position":2,"name":"Pharma Vendor and Ad Agency Diversity: All Talk, No Action?"}]},{"@type":"WebSite","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/","name":"Pharma Marketing Network","description":"Pharma Marketing Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1","name":"Pharma Guy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/","url":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","contentUrl":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","caption":"Pharma Guy"},"description":"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/"}]}},"_links":{"self":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/7383"}],"collection":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/comments?post=7383"}],"version-history":[{"count":1,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/7383\/revisions"}],"predecessor-version":[{"id":8845,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/7383\/revisions\/8845"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media\/13101"}],"wp:attachment":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media?parent=7383"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/categories?post=7383"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/tags?post=7383"},{"taxonomy":"topic","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/topic?post=7383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}